The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages.

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

In the case of the amyloid drugs, Eisai Biogen's Leqembi (lecanemab) and Eli Lilly's Kisunla (donanemab) – there are also ...

Recent research highlights carnosic acid, found in rosemary and sage, as a potential weapon against Alzheimer's. Scientists ...

The experts agreed that carnosic acid could potentially improve the inflammation that generally occurs in most aging brains. There are cautions however.

Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients ...

According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...

A simple blood test could reveal which early Alzheimer’s patients are most at risk for rapid decline. Researchers found that ...

FYI, the test isn't new. It's been around for a while. The study found that people with higher insulin resistance were up to ...

The revised label expands the brain-scan agent's use, and means that Vizamyl can now be used to diagnose Alzheimer's and predict the development of dementia due to disease, the company said. The ...

Insulin resistance detected by routine triglyceride-glucose (TyG) index can flag people with early Alzheimer's who are four ...

But recent policy changes are poised to make life significantly harder for Baby Boomers. “If you’re in your 60s or 70s, what ...